chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Therapeutic response unexpected, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (second shot hurt a little more/patients arm hurt for 2-3 days afterwards), INSOMNIA (difficulty sleeping/difficulty staying asleep) and THERAPEUTIC RESPONSE UNEXPECTED ( the patient is happy because he thinks that the vaccine may have helped his chronic fatigue.  the patient is happy because he thinks that the vaccine may have helped his chronic fatigue. ) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 016B21A) for COVID-19 vaccination. Concurrent medical conditions included Chronic fatigue and Nerve pain. Concomitant products included VITAMIN D3, ACETYLSALICYLIC ACID (ASPIRIN 81), BACLOFEN, FOLIC ACID, GABAPENTIN, CLONAZEPAM, IBUPROFEN, VORTIOXETINE HYDROBROMIDE (TRINTELLIX), OMEPRAZOLE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced VACCINATION SITE PAIN (second shot hurt a little more/patients arm hurt for 2-3 days afterwards), INSOMNIA (difficulty sleeping/difficulty staying asleep) and THERAPEUTIC RESPONSE UNEXPECTED ( the patient is happy because he thinks that the vaccine may have helped his chronic fatigue.  the patient is happy because he thinks that the vaccine may have helped his chronic fatigue. ). At the time of the report, VACCINATION SITE PAIN (second shot hurt a little more/patients arm hurt for 2-3 days afterwards), INSOMNIA (difficulty sleeping/difficulty staying asleep) and THERAPEUTIC RESPONSE UNEXPECTED ( the patient is happy because he thinks that the vaccine may have helped his chronic fatigue.  the patient is happy because he thinks that the vaccine may have helped his chronic fatigue. ) outcome was unknown. Not Provided. No treatment was provided by the reporter. This case was linked to MOD-2021-106849 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: The patient reports he doesn't travel and missed his appointment for his second dose and was unable to get his second dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (The patient reports he doesn't travel and missed his appointment for his second dose and was unable to get his second dose of the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (The patient reports he doesn't travel and missed his appointment for his second dose and was unable to get his second dose of the vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (The patient reports he doesn't travel and missed his appointment for his second dose and was unable to get his second dose of the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. Patient was on orthopedic therapy. No treatment information was provided.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: pulled syringe very fast so lots of Moderna vaccine dripping down on his arm; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (pulled syringe very fast so lots of Moderna vaccine dripping down on his arm) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced ACCIDENTAL UNDERDOSE (pulled syringe very fast so lots of Moderna vaccine dripping down on his arm). At the time of the report, ACCIDENTAL UNDERDOSE (pulled syringe very fast so lots of Moderna vaccine dripping down on his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Mass, Pruritus, Pustule, Pyrexia
Clinical narrative: itchy; bumpy; pustules; warm to touch; 6inch by 3 inch red spot at injection site; feverish; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), MASS (bumpy), PUSTULE (pustules), FEELING HOT (warm to touch) and VACCINATION SITE ERYTHEMA (6inch by 3 inch red spot at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D3 for an unknown indication, VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]).    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced PRURITUS (itchy), MASS (bumpy), PUSTULE (pustules), FEELING HOT (warm to touch), VACCINATION SITE ERYTHEMA (6inch by 3 inch red spot at injection site) and PYREXIA (feverish). At the time of the report, PRURITUS (itchy), MASS (bumpy), PUSTULE (pustules), FEELING HOT (warm to touch), VACCINATION SITE ERYTHEMA (6inch by 3 inch red spot at injection site) and PYREXIA (feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: itchy; bumpy; pustules; warm to touch; 6inch by 3 inch red spot at injection site; feverish; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), MASS (bumpy), PUSTULE (pustules), FEELING HOT (warm to touch) and VACCINATION SITE ERYTHEMA (6inch by 3 inch red spot at injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D3 for an unknown indication, VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]).    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced PRURITUS (itchy), MASS (bumpy), PUSTULE (pustules), FEELING HOT (warm to touch), VACCINATION SITE ERYTHEMA (6inch by 3 inch red spot at injection site) and PYREXIA (feverish). At the time of the report, PRURITUS (itchy), MASS (bumpy), PUSTULE (pustules), FEELING HOT (warm to touch), VACCINATION SITE ERYTHEMA (6inch by 3 inch red spot at injection site) and PYREXIA (feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Palpitations
Clinical narrative: Her heart was racing just a very little bit; She had dizziness for three to four days; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Her heart was racing just a very little bit) and DIZZINESS (She had dizziness for three to four days) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Smoker.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, the patient experienced PALPITATIONS (Her heart was racing just a very little bit) and DIZZINESS (She had dizziness for three to four days). On 03-Apr-2021, PALPITATIONS (Her heart was racing just a very little bit) had resolved. At the time of the report, DIZZINESS (She had dizziness for three to four days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-106537, US-MODERNATX, INC.-MOD-2021-106610 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106537:Brother case US-MODERNATX, INC.-MOD-2021-106610:Reporter's case
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Decreased appetite, Feeling cold, Headache
Clinical narrative: todos los mismos síntomas que cuando tuvo covid-19; sentía mucho frío; dolor de huesos; se le quitó el hambre; escalofríos; dolor de cabeza; tenía que ir al baño a cada rato; no pudo comer porque cualquier cosa la vomitaba; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), DECREASED APPETITE (se le quitó el hambre) and CHILLS (escalofríos) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), DECREASED APPETITE (se le quitó el hambre), CHILLS (escalofríos), HEADACHE (dolor de cabeza), NAUSEA (tenía que ir al baño a cada rato) and VOMITING (no pudo comer porque cualquier cosa la vomitaba). On 02-May-2021, VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), DECREASED APPETITE (se le quitó el hambre), NAUSEA (tenía que ir al baño a cada rato) and VOMITING (no pudo comer porque cualquier cosa la vomitaba) had resolved. At the time of the report, FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), CHILLS (escalofríos) and HEADACHE (dolor de cabeza) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were  not provided. No Treatment details were provided.   This case was linked to MOD21-087003, MOD21-087004, MOD21-087005, MOD21-087006, US-MODERNATX, INC.-MOD-2021-107093 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Non significant follow up received and contains no new information; Sender's Comments:  MOD21-087003:cross linked id MOD21-087004:cross linked id MOD21-087005:cross linked id MOD21-087006:cross linked id US-MODERNATX, INC.-MOD-2021-107093:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination complication, Vomiting
Clinical narrative: todos los mismos síntomas que cuando tuvo covid-19; sentía mucho frío; dolor de huesos; se le quitó el hambre; escalofríos; dolor de cabeza; tenía que ir al baño a cada rato; no pudo comer porque cualquier cosa la vomitaba; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), DECREASED APPETITE (se le quitó el hambre) and CHILLS (escalofríos) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), DECREASED APPETITE (se le quitó el hambre), CHILLS (escalofríos), HEADACHE (dolor de cabeza), NAUSEA (tenía que ir al baño a cada rato) and VOMITING (no pudo comer porque cualquier cosa la vomitaba). On 02-May-2021, VACCINATION COMPLICATION (todos los mismos síntomas que cuando tuvo covid-19), DECREASED APPETITE (se le quitó el hambre), NAUSEA (tenía que ir al baño a cada rato) and VOMITING (no pudo comer porque cualquier cosa la vomitaba) had resolved. At the time of the report, FEELING COLD (sentía mucho frío), BONE PAIN (dolor de huesos), CHILLS (escalofríos) and HEADACHE (dolor de cabeza) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were  not provided. No Treatment details were provided.   This case was linked to MOD21-087003, MOD21-087004, MOD21-087005, MOD21-087006, US-MODERNATX, INC.-MOD-2021-107093 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Non significant follow up received and contains no new information; Sender's Comments:  MOD21-087003:cross linked id MOD21-087004:cross linked id MOD21-087005:cross linked id MOD21-087006:cross linked id US-MODERNATX, INC.-MOD-2021-107093:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: headache; very mild fever; severe body ache; severe nausea; fatigue; splitting headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (very mild fever), MYALGIA (severe body ache), NAUSEA (severe nausea) and FATIGUE (fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic fatigue, Bowel obstruction and Digestion impaired.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced HEADACHE (headache), PYREXIA (very mild fever), MYALGIA (severe body ache), NAUSEA (severe nausea), FATIGUE (fatigue) and HEADACHE (splitting headache). At the time of the report, HEADACHE (headache), PYREXIA (very mild fever), MYALGIA (severe body ache), NAUSEA (severe nausea), FATIGUE (fatigue) and HEADACHE (splitting headache) outcome was unknown. Not Provided          No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-106954 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: hives; rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) and RASH (rash) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced URTICARIA (hives) and RASH (rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 UNK. At the time of the report, URTICARIA (hives) and RASH (rash) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable Concomitant medications include eye drops
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever of 103; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 103) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced PYREXIA (Fever of 103). At the time of the report, PYREXIA (Fever of 103) outcome was unknown. Not Provided          No concomitant medications were provided  No treatment details were given.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: First dose administered to a 17 yr old Pediatric patient; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 17 yr old Pediatric patient) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 17 yr old Pediatric patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose administered to a 17 yr old Pediatric patient) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Eye pain, Fatigue, Headache, Hot flush
Clinical narrative: feel like migraine; Disruption in sleep; pain in eyes; hot flashes; not sleeping well; Weak; tired; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (feel like migraine), SLEEP DISORDER (Disruption in sleep), EYE PAIN (pain in eyes), HOT FLUSH (hot flashes) and POOR QUALITY SLEEP (not sleeping well) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and SERTRALINE for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (Headache). On 16-Apr-2021, the patient experienced MIGRAINE (feel like migraine), SLEEP DISORDER (Disruption in sleep), EYE PAIN (pain in eyes), HOT FLUSH (hot flashes), POOR QUALITY SLEEP (not sleeping well), ASTHENIA (Weak) and FATIGUE (tired). On 16-Apr-2021, MIGRAINE (feel like migraine) and HEADACHE (Headache) had resolved. At the time of the report, SLEEP DISORDER (Disruption in sleep), EYE PAIN (pain in eyes), HOT FLUSH (hot flashes), POOR QUALITY SLEEP (not sleeping well), ASTHENIA (Weak) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Poor quality sleep, Sleep disorder
Clinical narrative: feel like migraine; Disruption in sleep; pain in eyes; hot flashes; not sleeping well; Weak; tired; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (feel like migraine), SLEEP DISORDER (Disruption in sleep), EYE PAIN (pain in eyes), HOT FLUSH (hot flashes) and POOR QUALITY SLEEP (not sleeping well) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and SERTRALINE for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (Headache). On 16-Apr-2021, the patient experienced MIGRAINE (feel like migraine), SLEEP DISORDER (Disruption in sleep), EYE PAIN (pain in eyes), HOT FLUSH (hot flashes), POOR QUALITY SLEEP (not sleeping well), ASTHENIA (Weak) and FATIGUE (tired). On 16-Apr-2021, MIGRAINE (feel like migraine) and HEADACHE (Headache) had resolved. At the time of the report, SLEEP DISORDER (Disruption in sleep), EYE PAIN (pain in eyes), HOT FLUSH (hot flashes), POOR QUALITY SLEEP (not sleeping well), ASTHENIA (Weak) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable. Treatment information was not provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: Reduced pain in knee left; Pain at injection site left; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection site left) and ARTHRALGIA (Reduced pain in knee left) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 044B21A) for COVID-19 vaccination.     The patient's past medical history included Knee arthritis (Prior to vaccine 2 month).   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site left). On 22-Mar-2021, the patient experienced ARTHRALGIA (Reduced pain in knee left). The patient was treated with NAPROXEN SODIUM (ALEVE) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (Pain at injection site left) and ARTHRALGIA (Reduced pain in knee left) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability, Pruritus, Vaccination site bruising, Vaccination site erythema, Vaccination site swelling
Clinical narrative: warm  to the touch at the injection site; feeling irritated and itchy; feeling irritated and itchy; injection site felt like a mosquito bite; puffiness at injection site/swelling of injection site; redness at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (warm  to the touch at the injection site), PRURITUS (feeling irritated and itchy), IRRITABILITY (feeling irritated and itchy), VACCINATION SITE BRUISING (injection site felt like a mosquito bite) and VACCINATION SITE SWELLING (puffiness at injection site/swelling of injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION SITE SWELLING (puffiness at injection site/swelling of injection site) and VACCINATION SITE ERYTHEMA (redness at injection site). On 30-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm  to the touch at the injection site), PRURITUS (feeling irritated and itchy), IRRITABILITY (feeling irritated and itchy) and VACCINATION SITE BRUISING (injection site felt like a mosquito bite). On 01-May-2021, VACCINATION SITE WARMTH (warm  to the touch at the injection site), PRURITUS (feeling irritated and itchy), IRRITABILITY (feeling irritated and itchy), VACCINATION SITE BRUISING (injection site felt like a mosquito bite), VACCINATION SITE SWELLING (puffiness at injection site/swelling of injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment medications included Tylenol, ice, and aloevera lotion
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: warm  to the touch at the injection site; feeling irritated and itchy; feeling irritated and itchy; injection site felt like a mosquito bite; puffiness at injection site/swelling of injection site; redness at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (warm  to the touch at the injection site), PRURITUS (feeling irritated and itchy), IRRITABILITY (feeling irritated and itchy), VACCINATION SITE BRUISING (injection site felt like a mosquito bite) and VACCINATION SITE SWELLING (puffiness at injection site/swelling of injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION SITE SWELLING (puffiness at injection site/swelling of injection site) and VACCINATION SITE ERYTHEMA (redness at injection site). On 30-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm  to the touch at the injection site), PRURITUS (feeling irritated and itchy), IRRITABILITY (feeling irritated and itchy) and VACCINATION SITE BRUISING (injection site felt like a mosquito bite). On 01-May-2021, VACCINATION SITE WARMTH (warm  to the touch at the injection site), PRURITUS (feeling irritated and itchy), IRRITABILITY (feeling irritated and itchy), VACCINATION SITE BRUISING (injection site felt like a mosquito bite), VACCINATION SITE SWELLING (puffiness at injection site/swelling of injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment medications included Tylenol, ice, and aloevera lotion
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Lymphadenopathy, Peripheral swelling
Clinical narrative: Shoulder is swollen; Under armpit is swollen; sore shoulder; Some swelling underneath and in my shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Shoulder is swollen), LYMPHADENOPATHY (Under armpit is swollen), ARTHRALGIA (sore shoulder) and AXILLARY PAIN (Some swelling underneath and in my shoulder) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 046A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Shoulder is swollen), LYMPHADENOPATHY (Under armpit is swollen), ARTHRALGIA (sore shoulder) and AXILLARY PAIN (Some swelling underneath and in my shoulder). At the time of the report, PERIPHERAL SWELLING (Shoulder is swollen), LYMPHADENOPATHY (Under armpit is swollen), ARTHRALGIA (sore shoulder) and AXILLARY PAIN (Some swelling underneath and in my shoulder) outcome was unknown. Not Provided          Concomitant medication involves: high blood pressure (unspecified)
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Eye discharge, Irritable bowel syndrome, Myalgia, Ocular hyperaemia, Rash macular
Clinical narrative: reddish dark mark on her left arm; left arm at injection site red; left arm at injection site swollen; left arm at injectio site itchy; Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless; drainage from both eyes; eyes were blood shot; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm was sore), EYE DISCHARGE (drainage from both eyes), OCULAR HYPERAEMIA (eyes were blood shot), IRRITABLE BOWEL SYNDROME (Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless) and VACCINATION SITE ERYTHEMA (left arm at injection site red) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL), BC powder, LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D), FAMOTIDINE (PEPCID AC), CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) and CALCIUM CARBONATE (TUMS 500 CALCIUM) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (arm was sore). On 02-Apr-2021, the patient experienced EYE DISCHARGE (drainage from both eyes) and OCULAR HYPERAEMIA (eyes were blood shot). On 07-Apr-2021, the patient experienced IRRITABLE BOWEL SYNDROME (Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless). On 09-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (left arm at injection site red), VACCINATION SITE SWELLING (left arm at injection site swollen) and VACCINATION SITE PRURITUS (left arm at injectio site itchy). On an unknown date, the patient experienced RASH MACULAR (reddish dark mark on her left arm). On 04-Apr-2021, MYALGIA (arm was sore), EYE DISCHARGE (drainage from both eyes) and OCULAR HYPERAEMIA (eyes were blood shot) had resolved. On 16-Apr-2021, VACCINATION SITE ERYTHEMA (left arm at injection site red), VACCINATION SITE SWELLING (left arm at injection site swollen) and VACCINATION SITE PRURITUS (left arm at injectio site itchy) had resolved. On 28-Apr-2021, IRRITABLE BOWEL SYNDROME (Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless) had resolved. At the time of the report, RASH MACULAR (reddish dark mark on her left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-107127 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: reddish dark mark on her left arm; left arm at injection site red; left arm at injection site swollen; left arm at injectio site itchy; Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless; drainage from both eyes; eyes were blood shot; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm was sore), EYE DISCHARGE (drainage from both eyes), OCULAR HYPERAEMIA (eyes were blood shot), IRRITABLE BOWEL SYNDROME (Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless) and VACCINATION SITE ERYTHEMA (left arm at injection site red) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL), BC powder, LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D), FAMOTIDINE (PEPCID AC), CLARITHROMYCIN (MACROBID [CLARITHROMYCIN]) and CALCIUM CARBONATE (TUMS 500 CALCIUM) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (arm was sore). On 02-Apr-2021, the patient experienced EYE DISCHARGE (drainage from both eyes) and OCULAR HYPERAEMIA (eyes were blood shot). On 07-Apr-2021, the patient experienced IRRITABLE BOWEL SYNDROME (Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless). On 09-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (left arm at injection site red), VACCINATION SITE SWELLING (left arm at injection site swollen) and VACCINATION SITE PRURITUS (left arm at injectio site itchy). On an unknown date, the patient experienced RASH MACULAR (reddish dark mark on her left arm). On 04-Apr-2021, MYALGIA (arm was sore), EYE DISCHARGE (drainage from both eyes) and OCULAR HYPERAEMIA (eyes were blood shot) had resolved. On 16-Apr-2021, VACCINATION SITE ERYTHEMA (left arm at injection site red), VACCINATION SITE SWELLING (left arm at injection site swollen) and VACCINATION SITE PRURITUS (left arm at injectio site itchy) had resolved. On 28-Apr-2021, IRRITABLE BOWEL SYNDROME (Irritable Bowel Syndrome (IBS) stared to act up/IBS was unusual and relentless) had resolved. At the time of the report, RASH MACULAR (reddish dark mark on her left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-107127 (Patient Link).
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Ear discomfort, Paraesthesia
Clinical narrative: Tingling in the ears/Experienced sensations in ears; dizziness; Nervous problem in ears; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the ears/Experienced sensations in ears), EAR DISCOMFORT (Nervous problem in ears) and DIZZINESS (dizziness) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PARAESTHESIA (Tingling in the ears/Experienced sensations in ears) and DIZZINESS (dizziness). On an unknown date, the patient experienced EAR DISCOMFORT (Nervous problem in ears). At the time of the report, DIZZINESS (dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-106762 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not provided by reporter. Treatment medication use was not provided by reporter.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Illness, Mobility decreased
Clinical narrative: Patient felt "lousy"; Patient couldn't do anything for 11 days; Patient felt tired; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient felt "lousy"), MOBILITY DECREASED (Patient couldn't do anything for 11 days) and FATIGUE (Patient felt tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ILLNESS (Patient felt "lousy"), MOBILITY DECREASED (Patient couldn't do anything for 11 days) and FATIGUE (Patient felt tired). At the time of the report, ILLNESS (Patient felt "lousy"), MOBILITY DECREASED (Patient couldn't do anything for 11 days) and FATIGUE (Patient felt tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported No treatment medications were reported    This case was linked to MOD-2021-106981 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: 6 patients received vaccine stored 32 days in refrigirator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (6 patients received vaccine stored 32 days in refrigirator) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced PRODUCT STORAGE ERROR (6 patients received vaccine stored 32 days in refrigirator). At the time of the report, PRODUCT STORAGE ERROR (6 patients received vaccine stored 32 days in refrigirator) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up received on 07-May-2021 and contains no new information
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 42 days have passed since 1st shot for a patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days have passed since 1st shot for a patient) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days have passed since 1st shot for a patient). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days have passed since 1st shot for a patient) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue, Rash
Clinical narrative: arm was hurting; large rash; did not receive second dose in dosing window; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting), RASH (large rash) and PRODUCT DOSE OMISSION ISSUE (did not receive second dose in dosing window) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was hurting), RASH (large rash) and PRODUCT DOSE OMISSION ISSUE (did not receive second dose in dosing window). At the time of the report, PAIN IN EXTREMITY (arm was hurting) and RASH (large rash) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (did not receive second dose in dosing window) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Nausea, Pain
Clinical narrative: slept all 3 days; body aches; mild nausea; Exhaustion was much worse; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (slept all 3 days), PAIN (body aches), NAUSEA (mild nausea) and FATIGUE (Exhaustion was much worse) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 003B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced HYPERSOMNIA (slept all 3 days), PAIN (body aches), NAUSEA (mild nausea) and FATIGUE (Exhaustion was much worse). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (slept all 3 days), PAIN (body aches), NAUSEA (mild nausea) and FATIGUE (Exhaustion was much worse) outcome was unknown.            Concomitant medication was not provided Treatment medication include tylenol .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-106884 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on their front and back torso; rash on back only; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on their front and back torso) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included letrovole for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced RASH (Rash on their front and back torso). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-107053 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Urticaria
Clinical narrative: hives on the arm; the arm swelled; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives on the arm) and PERIPHERAL SWELLING (the arm swelled) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives on the arm) and PERIPHERAL SWELLING (the arm swelled). At the time of the report, URTICARIA (hives on the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-086957, MOD21-087003, MOD21-087005, MOD21-087006, US-MODERNATX, INC.-MOD-2021-107093 (Linked Report).; Sender's Comments:  MOD21-086957: MOD21-087003: MOD21-087005: MOD21-087006: US-MODERNATX, INC.-MOD-2021-107093:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain
Clinical narrative: shooting pain that started in the arm and traveled down to the hand (left); numbness in the hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (shooting pain that started in the arm and traveled down to the hand (left)) and HYPOAESTHESIA (numbness in the hand) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CLOMIFENE CITRATE (CLOMID), LABETALOL, LEVOTHYROXINE SODIUM (SYNTHROID), METFORMIN, CETIRIZINE, FOLIC ACID, CITALOPRAM, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), EXENATIDE (BYDUREON), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), OMEPRAZOLE, CEFIXIME (FLEXERIL [CEFIXIME]), NAPROXEN and PANTOPRAZOLE for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (shooting pain that started in the arm and traveled down to the hand (left)) and HYPOAESTHESIA (numbness in the hand). At the time of the report, PAIN (shooting pain that started in the arm and traveled down to the hand (left)) and HYPOAESTHESIA (numbness in the hand) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.